STAT3 is constitutively activated in many human cancers with poor prognosis or chemo- or radio-resistance, which have been molecularly linked through cancer genome landscape studies to increased tyrosine kinase signaling in particular [41–43]. The gene discussed is STAT3; the disease is cancer.